An exciting new perspective has arisen from work by the Reis e Sousa lab demonstrating that tumours exploit the systemic actin scavenging system to prevent cross-presentation of tumour antigens by DCs via DNGR1/Clec9a [36]. Here, CLEC9A is linked to neoplasm.